Aging
Navigate
Editorial|Volume 8, Issue 6|pp 1159—1160

Targeting mutant p53 for cancer therapy

Moshe Oren, Perry Tal, Varda Rotter
  • 1Department of Molecular Cell Biology, The Weizmann Institute, Rehovot 76100, Israel
Received: June 16, 2016Published: June 26, 2016

Copyright: © 2016 et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.